These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

269 related items for PubMed ID: 18478155

  • 1. Treatment of central precocious puberty by GnRH analogs: long-term outcome in men.
    Bertelloni S, Mul D.
    Asian J Androl; 2008 Jul; 10(4):525-34. PubMed ID: 18478155
    [Abstract] [Full Text] [Related]

  • 2. Body mass index and body composition in adolescents treated with gonadotropin-releasing hormone analogue triptorelin depot for central precocious puberty: data at near final height.
    Chiocca E, Dati E, Baroncelli GI, Mora S, Parrini D, Erba P, Bertelloni S.
    Neuroendocrinology; 2009 Jul; 89(4):441-7. PubMed ID: 19176945
    [Abstract] [Full Text] [Related]

  • 3. Auxological outcome and time to menarche following long-acting goserelin therapy in girls with central precocious or early puberty.
    Paterson WF, McNeill E, Young D, Donaldson MD.
    Clin Endocrinol (Oxf); 2004 Nov; 61(5):626-34. PubMed ID: 15521967
    [Abstract] [Full Text] [Related]

  • 4. Adult height, body mass index and time of menarche of girls with idiopathic central precocious puberty after gonadotropin-releasing hormone analogue treatment.
    Poomthavorn P, Suphasit R, Mahachoklertwattana P.
    Gynecol Endocrinol; 2011 Aug; 27(8):524-8. PubMed ID: 21501002
    [Abstract] [Full Text] [Related]

  • 5. [Impact of gonadotropin-releasing hormone analogs treatment on final height in girls with central precocious puberty].
    Chen SK, Fan X, Tang Q.
    Zhongguo Dang Dai Er Ke Za Zhi; 2009 May; 11(5):374-6. PubMed ID: 19470261
    [Abstract] [Full Text] [Related]

  • 6. Does GnRH analog improve the final height in Thai girls with idiopathic central precocious puberty?
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S, Trinavarat P.
    J Med Assoc Thai; 2001 Jun; 84 Suppl 1():S51-6. PubMed ID: 11529380
    [Abstract] [Full Text] [Related]

  • 7. Consensus statement on the use of gonadotropin-releasing hormone analogs in children.
    Carel JC, Eugster EA, Rogol A, Ghizzoni L, Palmert MR, ESPE-LWPES GnRH Analogs Consensus Conference Group, Antoniazzi F, Berenbaum S, Bourguignon JP, Chrousos GP, Coste J, Deal S, de Vries L, Foster C, Heger S, Holland J, Jahnukainen K, Juul A, Kaplowitz P, Lahlou N, Lee MM, Lee P, Merke DP, Neely EK, Oostdijk W, Phillip M, Rosenfield RL, Shulman D, Styne D, Tauber M, Wit JM.
    Pediatrics; 2009 Apr; 123(4):e752-62. PubMed ID: 19332438
    [Abstract] [Full Text] [Related]

  • 8. [Impact of gonadotropin-releasing hormone analogs on body mass index in girls with idiopathic central precocious puberty: a long-term follow-up study].
    Yuan JN, Liang L, Cai XD, Li Z, Bai M, Gu CP.
    Zhongguo Dang Dai Er Ke Za Zhi; 2011 Nov; 13(11):896-9. PubMed ID: 22099200
    [Abstract] [Full Text] [Related]

  • 9. Precocious puberty and statural growth.
    Carel JC, Lahlou N, Roger M, Chaussain JL.
    Hum Reprod Update; 2004 Nov; 10(2):135-47. PubMed ID: 15073143
    [Abstract] [Full Text] [Related]

  • 10. [Consensus on the diagnosis and treatment of central early puberty].
    García H, Youlton R, Burrows R, Catanni A, Rama de Endocrinologia Pediatrica de la Sociedad Chilena de Pediatria.
    Rev Med Chil; 2003 Jan; 131(1):95-110. PubMed ID: 12643227
    [Abstract] [Full Text] [Related]

  • 11. Update on therapy for precocious puberty.
    Wheeler MD.
    Compr Ther; 1994 Jan; 20(6):351-5. PubMed ID: 8062545
    [Abstract] [Full Text] [Related]

  • 12. Efficacy of combined treatment with growth hormone and gonadotropin releasing hormone analogue in children with poor prognosis of adult height.
    Toumba M, Bacopoulou I, Savva SC, Skordis N.
    Indian Pediatr; 2007 Jul; 44(7):497-502. PubMed ID: 17684302
    [Abstract] [Full Text] [Related]

  • 13. Long-acting GnRH analogue triptorelin therapy in central isosexual precocious puberty.
    Bajpai A, Sharma J, Kabra M, Gupta AK, Menon PS.
    Indian Pediatr; 2002 Jul; 39(7):633-9. PubMed ID: 12147888
    [Abstract] [Full Text] [Related]

  • 14. Final adult height in "early normal pubertal girls" treated with gonadotropin releasing hormone agonists.
    Wacharasindhu S, Srivuthana S, Aroonparkmongkol S, Supornsilchai V, Hiranrat P, Yodvisitsak V.
    J Med Assoc Thai; 2003 Jun; 86 Suppl 2():S170-3. PubMed ID: 12929985
    [Abstract] [Full Text] [Related]

  • 15. The histrelin implant: a novel treatment for central precocious puberty.
    Hirsch HJ, Gillis D, Strich D, Chertin B, Farkas A, Lindenberg T, Gelber H, Spitz IM.
    Pediatrics; 2005 Dec; 116(6):e798-802. PubMed ID: 16322137
    [Abstract] [Full Text] [Related]

  • 16. Combined use of growth hormone and gonadotropin-releasing hormone analogues in precocious puberty: theoretic and practical considerations.
    Walvoord EC, Pescovitz OH.
    Pediatrics; 1999 Oct; 104(4 Pt 2):1010-4. PubMed ID: 10506253
    [Abstract] [Full Text] [Related]

  • 17. Advances in the treatment of precocious puberty.
    Kappy MS, Ganong CS.
    Adv Pediatr; 1994 Oct; 41():223-61. PubMed ID: 7992685
    [Abstract] [Full Text] [Related]

  • 18. Long-term GnRH agonist treatment for female central precocious puberty does not impair reproductive function.
    Heger S, Müller M, Ranke M, Schwarz HP, Waldhauser F, Partsch CJ, Sippell WG.
    Mol Cell Endocrinol; 2006 Jul 25; 254-255():217-20. PubMed ID: 16757104
    [Abstract] [Full Text] [Related]

  • 19. [Central precocious puberty].
    Brauner R, Rappaport R.
    Ann Pediatr (Paris); 1989 Dec 25; 36(10):653-8. PubMed ID: 2696410
    [Abstract] [Full Text] [Related]

  • 20. Long-term treatment of familial male-limited precocious puberty (testotoxicosis) with cyproterone acetate or ketoconazole.
    Almeida MQ, Brito VN, Lins TS, Guerra-Junior G, de Castro M, Antonini SR, Arnhold IJ, Mendonca BB, Latronico AC.
    Clin Endocrinol (Oxf); 2008 Jul 25; 69(1):93-8. PubMed ID: 18088394
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.